How RNA Biomarkers Could Help Diagnose Heart Disease
A new study Journal of Molecular and Cellular Cardiology Plus demonstrates how RNA biomarkers may be used to confirm heart disease.
A new study Journal of Molecular and Cellular Cardiology Plus demonstrates how RNA biomarkers may be used to confirm heart disease.
The study analyzes foamy macrophages to see how their lipid consumption related to heart attacks, arthritis, and even irritable bowel syndrome.
Every 9 minutes, someone in a US hospital dies due to a medical diagnosis that was wrong or delayed.
The campaign is focused on empowering patients with lung cancer and their caregivers to initiate a dialogue with their physicians about comprehensive genomic testing and its potential to expand treatment options for the patient.
Read MoreThe simple blood test identifies individuals who are at risk of experiencing a heart attack, and for whom early intervention can help.
Read MoreAnalysis utilizing single-molecule counting technology developed by Singulex has shown the power to identify patients at risk for worsening heart health.
Read MoreThe collaboration aims to address unmet needs to guide clinical decisions in breast cancer.
Read MoreCurrent and emerging cardiac markers are signaling improved testing for better patient outcomes.
Read MoreAbridged and edited results of a live Q&A session with Donna Mayne, BS, MT(ASCP), (CLS)NCA, microbiology and molecular laboratory manager at Sacred Heart Hospital Pensacola Laboratory, during CLP’s well-attended webcast on “Bacterial Vaginosis: Complications and Diagnostic Options.”
Read MoreNIAID study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Read MoreResearchers seek to better understand the genomic basis of disease, and provide tailored care to patients.
Read MoreReshaping and broadening the future of lab testing, these diagnostic advances are particularly noteworthy for laboratorians as well as for physicians and patients.
Read MoreWith the prevalence of diabetes continuing on an upward trajectory both in the United States and overseas, healthcare professionals are continuing to search for more effective methods of preventing, detecting, and treating the disease.
Read MoreWhen it comes to women’s health, molecular diagnostics are playing a bigger role than ever before in uncovering how sex differences are expressed in cancer.
Read MoreThe Abbott Innovation Roundtable at AACC highlighted the company’s latest strides forwards in the molecular diagnostics, point-of-care, and bio-identification sectors.
Read MoreNotable breakthroughs in personalized medicine continue, but reimbursement hurdles and regulation concerns have posed occasional setbacks.
Read MoreLaboratory testing plays a vital role in keeping tabs on aging women.
Read MoreLabs play a vital role in testing women for heart disease.
Read More